Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Memorandum and Articles of Association
- 3.2 Form of Amended and Restated Memorandum and Articles of Association
- 4.1 Specimen Class a Ordinary Share Certificate
- 5.1 Opinion of Maples and Calder
- 10.1 Promissory Note, Dated January 14, 2021 Issued to ECOR1 Panacea Holdings II, LLC
- 10.2 Form of Letter Agreement Among the Registrant, the Registrant's Officers and Directors and ECOR1 Panacea Holdings II, LLC
- 10.3 Form of Investment Management Trust Agreement Between Continental Stock Transfer & Trust Company and the Registrant
- 10.4 Form of Registration Rights Agreement Among the Registrant, ECOR1 Panacea Holdings II, LLC and Certain Security Holders
- 10.5 Securities Subscription Agreement, Dated January 14, 2021, Between the Registrant and ECOR1 Panacea Holdings II, LLC
- 10.6 Form of Private Placement Share Purchase Agreement Between the Registrant and ECOR1 Panacea Holdings II, LLC
- 10.7 Form of Indemnity Agreement
- 10.8 Form of Administrative Services Agreement, Between the Registrant and ECOR1 Capital, LLC
- 10.9 Form of Forward Purchase Agreement, Among the Registrant, ECOR1 Panacea Holdings II, LLC, ECOR1 Capital Fund, L.P. and ECOR1 Capital Fund Qualified, L.P.
- 14 Form of Code of Ethics and Business Conduct
- 23.1 Consent of Withumsmith+brown, PC
- 99.1 Consent of Douglas Giordano
- 99.2 Consent of Nina Kjellson
- 99.3 Consent of Praveen Tipirneni
- 99.4 Consent of Douglas E. Williams
Associated filings
- 18 Apr 23 25-NSE Exchange delisting
- 8 Apr 21 424B4 Prospectus supplement with pricing info
- 7 Apr 21 EFFECT Notice of effectiveness
-
9 Mar 21 S-1 IPO registration
Filing view
External links
Exhibit 99.1
Consent of INDEPENDENT DIRECTOR
In connection with the filing by Panacea Acquisition Corp. II (the “Company”) of its Registration Statement (the “Registration Statement”) on Form S-1 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments and supplements thereto.
Dated: March 5, 2021 | |
/s/ Douglas Giordano | |
Douglas Giordano |